Julie Vose: The long awaited publication from the NAMCL Project
Julie Vose shared a post on X/Twitter:
”Finally! The long awaited publication from the NAMCL Project! Read further.”
Source: Julie Vose/X
Julie Vose is the Neumann M. and Mildred E. Harris Professor and Chief in the Division of Oncology/Hematology at University of Nebraska Medical Center (UNMC). Dr. Vose was the 2015-16 President of the American Society of Clinical Oncology (ASCO). In addition to that, she also served on the ASCO Board of Directors, Special Awards Selection, Nominating, and Scientific Program Committees, Health Disparities Committee, Hematology-Oncology Task Force, Cancer.Net Advisory Panel and Editorial Board, and Journal of Clinical Oncology Editorial Board.
She also served as Chair of the Cancer Education Committee and Publications Committee. Dr. Vose was Co-Chair of the Lymphoma Steering Committee for the National Cancer Institute and has served on the U.S. Food and Drug Administration (FDA) Biologics Committee and the FDA Oncologic Drugs Advisory Committee (ODAC).
She also served as Education Committee Chair for the American Society of Hematology and Education Committee Chair for the American Society of Bone Marrow Transplantation. In addition, Dr. Vose served as Journal Editor of Leukemia and Lymphoma, is on three additional editorial boards, and is a reviewer for 10 journals.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023